Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft

Agreement expands access to the Cerapedics portfolio of peptide-powered drug-device products for spinal fusion procedures WESTMINSTER, Colo., April 24, 2026 /PRNewswire/ -- Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair,...